Dovish Fed Lifts IBB
Receding expectations for Fed rate hikes are driving capital into rate-sensitive growth sectors like biotechnology.
Previous verdicts for IBB
- AI Search: Biotech Partnerships Lift iShares Biotechnology ETF Modestly Higher — 2026-11-09
- AI Search: Novartis Pipeline Setback Weighs on Biotech Sentiment — 2026-11-08
- Biotech Rotation — 2026-10-15
- Bio Defensive Play — 2026-08-19
- Rate Fears Hit Growth — 2026-08-14
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works